US Patent

US10576156 — Compositions for drug administration

Formulation · Assigned to Aegis Therapeutics LLC · Expires 2038-02-06 · 12y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects compositions that include an alkyl glycoside and a therapeutic agent, designed to increase the bioavailability of the agent.

USPTO Abstract

The present invention provides compositions and methods and for increasing the bioavailability of therapeutic agents in a subject. The compositions include at least one alkyl glycoside and at least one therapeutic agent, wherein the alkylglycoside has an alkyl chain length from about 10 to about 16 carbon atoms.

Drugs covered by this patent

Patent Metadata

Patent number
US10576156
Jurisdiction
US
Classification
Formulation
Expires
2038-02-06
Drug substance claim
No
Drug product claim
Yes
Assignee
Aegis Therapeutics LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.